| Financial Year |
March 31 2023 |
| Monetary Funds |
784,389,452.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
57,404,277.94 |
| Accounts Receivable |
3,057,587,851.06 |
| Advances to Suppliers |
161,174,898.05 |
| Other Receivables |
51,038,409.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,745,345,535.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,505,555.55 |
| Other Current Assets |
327,259,295.84 |
| Total Current Assets |
6,923,394,476.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,664,620.34 |
| Long-term Equity Investment |
11,025,454.26 |
| Investment Properties |
-- |
| Fixed Assetes |
3,482,351,463.80 |
| Under-construction Projects |
453,220,149.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,138,470,005.28 |
| R&D expenses |
149,801,770.77 |
| Goodwill |
1,678,501,491.83 |
| Long-Term Deferred and Prepaid Expenses |
30,442,671.59 |
| Deferred Income Tax Assets |
371,455,214.17 |
| Other Non-Current Assets |
805,978,307.51 |
| Sub-Total of Non-Current Assets |
8,674,560,909.95 |
| Total Assets |
15,597,955,386.68 |
| Short-Term Loans |
1,691,497,164.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,671,854.95 |
| Accounts Payable |
2,923,423,386.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
542,779,718.19 |
| Taxes Payable |
223,474,631.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
339,193,548.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
610,540,363.74 |
| Other Current Liabilities |
216,129,836.33 |
| Sub-Total of Current Liabilities |
6,795,811,618.18 |
| Long-term Loans |
2,692,272,570.33 |
| Bonds Payable |
361,611,664.10 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
411,164,223.94 |
| Other Non-Current Liabilities |
19,909,192.55 |
| Sub-Total of Non-Current Liabilities |
4,845,393,397.26 |
| Total Liabilities |
11,641,205,015.44 |
| Paid-In Capital(Or Share Stock) |
1,126,235,789.00 |
| Capital Surplus |
3,497,609,658.35 |
| Surplus Reserve |
221,996,279.40 |
| LESS:Treasury Stock |
52,686,110.00 |
| Undistributed Profits |
-1,085,876,300.07 |
| Minority Stockholder's Interest |
323,403,253.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,633,347,117.40 |
| Owner's Equity（Stockholder's Equity） |
3,956,750,371.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,597,955,386.68 |
